Trial Profile
Effects of escitalopram for post stroke depressive patients : evaluated by QIDS-J
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2019
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 25 Aug 2019 Status changed from not yet recruiting to completed.
- 15 Mar 2014 New trial record